Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Crossover Experiments01:16

Crossover Experiments

2.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K
Randomized Experiments01:13

Randomized Experiments

7.0K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.0K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Blind Procedures02:07

Blind Procedures

10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Blinding01:11

Blinding

2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical Record Abstraction for Quality Improvement in Sepsis Care Using Artificial Intelligence: A Cluster Randomized Trial.

JAMA network open·2026
Same author

Contusion Volume is a Cross-cohort Predictor of Delayed Seizures after Traumatic Brain Injury.

medRxiv : the preprint server for health sciences·2026
Same author

The SMART-of-1 approach to personalized treatment trials.

Journal of biopharmaceutical statistics·2026
Same author

Gray Matter Morphological Networks are Associated with Neurobiological Features, Cognitive Status and Clinical Recovery in Traumatic Brain Injury.

medRxiv : the preprint server for health sciences·2026
Same author

Inflammatory blood-based biomarkers to aid in the assessment and prognostication of traumatic brain injury: a TRACK-TBI study.

Journal of neuroinflammation·2026
Same author

Ocular Hypertension Treatment Study: Effect of Time After Incident Glaucoma on OCT Optic Nerve Head and Macula Measurements.

American journal of ophthalmology·2026

Related Experiment Video

Updated: Jul 8, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Addressing sequential and concurrent treatment regimens in a small n sequential, multiple assignment, randomized

Yuwei Cheng1, Adriana Tremoulet2, Jane Burns2

  • 1Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA.

Journal of Biopharmaceutical Statistics
|December 14, 2023
PubMed
Summary

A modified Bayesian model enhances analysis of concurrent versus sequential treatments for Multisystem Inflammatory Syndrome in children (MIS-C). This approach improves accuracy in evaluating therapies for this rare COVID-19 complication.

Keywords:
Bayesian joint stage modelClinical trial designSMART designrare disease

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

544

Related Experiment Videos

Last Updated: Jul 8, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

544

Area of Science:

  • Pediatric infectious diseases
  • Clinical trial methodology
  • Biostatistics

Background:

  • Multisystem Inflammatory Syndrome in children (MIS-C) is a rare complication of COVID-19, first identified in 2020.
  • The MISTIC study used a small n, Sequential, Multiple Assignment, Randomized Trial (snSMART) to evaluate treatments like steroids, infliximab, and anakinra.
  • Concurrent treatment administration was necessary due to disease urgency, posing analytical challenges for the standard snSMART design.

Purpose of the Study:

  • To propose a modified Bayesian joint stage model for analyzing concurrent versus sequential treatments in MIS-C clinical trials.
  • To address the limitations of the standard snSMART design when treatments are not strictly sequential.
  • To improve the accuracy and efficiency of estimating treatment response rates in complex trial designs.

Main Methods:

  • Development of a modified Bayesian joint stage model capable of distinguishing concurrent and sequential treatment effects.
  • Application of the model to analyze data from the MISTIC snSMART study.
  • Conducting a simulation study to compare the modified model with the standard snSMART Bayesian joint stage model.

Main Results:

  • The modified Bayesian model demonstrated improved accuracy and efficiency in estimating first-stage and combined first- and second-stage treatment responses.
  • Simulations showed reduced bias and improved root mean squared error (rMSE) for the modified model, particularly in large sample settings.
  • The proposed model effectively analyzes concurrent and sequential treatment administration within a unified framework.

Conclusions:

  • The modified Bayesian joint stage model offers a pragmatic and effective approach for analyzing clinical trials with concurrent and sequential treatment designs, such as in MIS-C studies.
  • This methodological advancement enhances the ability to evaluate complex treatment strategies in rare and urgent pediatric conditions.
  • The findings support the use of this modified model for more precise and efficient clinical trial data analysis.